Mineralocorticoid and glucocorticoid receptors stimulate epithelial sodium channel activity in a mouse model of cushing syndrome

Hypertension

Volumn 54, Issue 4, 2009, Pages 890-896

  Bailey, Matthew A ^a   Mullins, John J ^a   Kenyon, Christopher J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; Amiloride; Furosemide; Renal clearance; Tubular sodium reabsorption

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SODIUM CHANNEL; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SPIRONOLACTONE; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CUSHING SYNDROME; DOWN REGULATION; GLOMERULUS FILTRATION; HENLE LOOP; HYPERTENSION; KIDNEY FUNCTION; MALE; MOUSE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; SODIUM ABSORPTION; SODIUM DEPLETION; SODIUM EXCRETION; SODIUM TRANSPORT;

ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CUSHING SYNDROME; DISEASE MODELS, ANIMAL; EPITHELIAL SODIUM CHANNEL; GLOMERULAR FILTRATION RATE; HORMONE ANTAGONISTS; LOOP OF HENLE; MALE; MICE; MICE, INBRED C57BL; MIFEPRISTONE; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, VASOPRESSIN; SODIUM; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; SPIRONOLACTONE;

EID: 70349653023     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.134973     Document Type: Article

References (49)

1. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab. 1986;62:275-279.
2. Ferrari P. Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. Best Pract Res Clin Endocrinol Metab. 2003;17:575-589.
3. Whitworth JA. Mechanisms of glucocorticoid-induced hypertension. Kidney Int. 1987;31:1213-1224.
4. Clore JN, Estep H, Ross-Clunis H, Watlington CO. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486. J Clin Endocrinol Metab. 1988;67:824-831.
5. Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertens. 1987;5:425-433.
6. Lohmeier TE, Kastner PR. Chronic effects of ACTH and cortisol excess on arterial pressure in normotensive and hypertensive dogs. Hypertension. 1982; 4:652-661.
7. Honda M, Nowaczynski W, Guthrie GP Jr, Messerli FH, Tolis G, Kuchel O, Genest J. Response of several adrenal steroids to ACTH stimulation in essential hypertension. J Clin Endocrinol Metab. 1977;44:264-272.
8. Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab. 1996;81:2797-2800.
9. Al-Dujaili EA, Mullins LJ, Bailey MA, Kenyon CJ. Development of a highly sensitive ELISA for aldosterone in mouse urine: Validation in physiological and pathophysiological states of aldosterone excess and depletion. Steroids. 2009;74:456-462.
10. Woods LL, Mizelle HL, Hall JE. Control of sodium excretion in NE-ACTH hypertension: role of pressure natriuresis. Am J Physiol. 1988; 255:R894-R900.
11. Montrella-Waybill M, Clore JN, Schoolwerth AC, Watlington CO. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor. J Clin Endocrinol Metab. 1991;72:1060-1066.
12. Feraille E, Doucet A. Sodium-potassium-adenosinetriphosphatasedependent sodium transport in the kidney: hormonal control. Physiol Rev. 2001;81:345-418.
13. Bobulescu IA, Dwarakanath V, Zou L, Zhang J, Baum M, Moe OW. Glucocorticoids acutely increase cell surface Na+/H+exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol. 2005;289:F685-F691.
14. Stanton BA. Regulation by adrenal corticosteroids of sodium and potassium transport in loop of Henle and distal tubule of rat kidney. J Clin Invest. 1986;78:1612-1620.
15. Velazquez H, Bartiss A, Bernstein P, Ellison DH. Adrenal steroids stimulate thiazide-sensitive NaCl transport by rat renal distal tubules. Am J Physiol Renal Physiol. 1996;270:F211-F219.
16. Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, Horisberger JD, Rossier BC. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosteronestimulated sodium transport in a novel renal cell line. J Am Soc Nephrol. 2005;16:878-891.
17. Kenyon CJ, Saccoccio NA, Morris DJ. Glucocorticoid inhibition of mineralocorticoid action in the rat. Clin Sci (Lond). 1984;67:329-335.
18. Bailey MA, Paterson JM, Hadoke PW, Wrobel N, Bellamy CO, Brownstein DG, Seckl JR, Mullins JJ. A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess. J Am Soc Nephrol. 2008;19:47-58.
19. Homer NZ, Reynolds RM, Mattsson C, Bailey MA, Walker BR, Andrew R. Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:497-501.
20. MacDonald P, MacKenzie S, Ramage LE, Seckl JR, Brown RW. Corticosteroid regulation of amiloride-sensitive sodium-channel subunit mRNA expression in mouse kidney. J Endocrinol. 2000;165:25-37.
21. Loffing J, Flores SY, Staub O. Sgk kinases and their role in epithelial transport. Annu Rev Physiol. 2006;68:461-490.
22. George CR. Non-specific enhancement of glomerular filtration by corticosteroids [letter]. Lancet. 1974;2:728-729.
23. Douglas JG. Corticosteroids decrease glomerular angiotensin receptors. Am J Physiol Renal Physiol. 1987;252:F453-F457.
24. Hostetter TH. Hyperfiltration and glomerulosclerosis. Sem Nephrol. 2003;23:194-199.
25. Elkjaer ML, Kwon TH, Wang W, Nielsen J, Knepper MA, Frokiaer J, Nielsen S. Altered expression of renal NHE3, TSC, BSC-1, and ENaC subunits in potassium-depleted rats. Am J Physiol Renal Physiol. 2002; 283:F1376-F1388.
26. Findling JW, Adams ND, Lemann J Jr, Gray RW, Thomas CJ, Tyrrell JB. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab. 1982;54:1039-1044.
27. Lorenz JN, Loreaux EL, Dostanic-Larson I, Lasko V, Schnetzer JR, Paul RJ, Lingrel JB. ACTH-induced hypertension is dependent on the ouabainbinding site of the alpha2-Na+-K+-ATPase subunit. Am J Physiol Heart Circ Physiol. 2008;295:H273-H280.
28. Walter SJ, Shirley DG, Folkerd EJ, Unwin RJ. Effects of the potassium channel blocker barium on sodium and potassium transport in the rat loop of Henle in vivo. Exp Physiol. 2001;86:469-474.
29. Kleyman TR, Cragoe EJ Jr. The mechanism of action of amiloride. Sem Nephrol. 1988;8:242-248.
30. Bailey MA, Cantone A, Yan Q, MacGregor GG, Leng Q, Amorim JB, Wang T, Hebert SC, Giebisch G, Malnic G. Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. Kidney Int. 2006;70: 51-59.
31. Cantone A, Yang X, Yan Q, Giebisch G, Hebert SC, Wang T. Mouse model of type II Bartter's syndrome: I- upregulation of thiazide-sensitive Na-Cl cotransport activity. Am J Physiol Renal Physiol. 2008;294: F1366-F1372.
32. Romano G, Favret G, Federico E, Bartoli E. The site of action of furosemide. Pharmacol Res. 1998;37:409-419.
33. Nielsen J, Kwon TH, Frokiaer J, Knepper MA, Nielsen S. Maintained ENaC trafficking in aldosterone-infused rats during mineralocorticoid and glucocorticoid receptor blockade. Am J Physiol Renal Physiol. 2007; 292:F382-F394.
34. Li M, Wen C, Fraser T, Whitworth JA. Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism. J Hypertens. 1999;17:419-426.
35. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988; 242:583-585.
36. Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CH. 11-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1995;80:3617-3620.
37. Albiston AL, Matsacos D, McDougall J. Increased ACTH levels do not alter renal 11-hydroxysteroid dehydrogenase type 2 gene expression in the sheep. Endocr J. 2001;48:119-122.
38. Diederich S, Quinkler M, Miller K, Heilmann P, Schoneshofer M, Oelkers W. Human kidney 11β-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin? Eur J Endocrinol. 1996;134:301-307.
39. Schulz-Baldes A, Berger S, Grahammer F, Warth R, Goldschmidt I, Peters J, Schutz G, Greger R, Bleich M. Induction of the epithelial Na+ channel via glucocorticoids in mineralocorticoid receptor knockout mice. Pflugers Arch. 2001;443:297-305.
40. Nguyen Dinh Cat A, Ouvrard-Pascaud A, Tronche F, Clemessy M, Gonzalez-Nunez D, Farman N, Jaisser F. Conditional transgenic mice for studying the role of the glucocorticoid receptor in the renal collecting duct. Endocrinology. 2009;150:2202-2210.
41. Ronzaud C, Loffing J, Bleich M, Gretz N, Grone HJ, Schutz G, Berger S. Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. J Am Soc Nephrol. 2007;18:1679-1687.
42. Stocker SD, Osborn JL, Carmichael SP. Forebrain osmotic regulation of the sympathetic nervous system. Clin Exp Pharmacol Physiol. 2008;35: 695-700.
43. Li M, Whitworth JA. Role of the sympathetic nervous system in the onset of hypertension in the rat: the effect of 6-OH-dopamine. Clin Exp Pharmacol Physiol. 1991;18:197-204.
44. Fraser TB, Turner SW, Wen C, Li M, Burrell LM, Whitworth JA. Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophininduced hypertension in the rat. Clin Exp Pharmacol Physiol. 2000;27: 866-870.
45. Whitworth JA, Hewitson TD, Cornwallis C. Corticotropin effects on blood pressure and fluid and electrolyte homeostasis in five strains of rats. Am J Hypertens. 1992;5:302-313.
46. Iijima F, Malik KU. Contribution of vasopressin in dexamethasone-induced hypertension in rats. Hypertension. 1988;11:I42- 46.
47. Tsai YH, Ohkita M, Gariepy CE. Chronic high-sodium diet increases aortic wall endothelin-1 expression in a blood pressure-independent fashion in rats. Exp Biol Med. 2006;231:813-817.
48. Amstislavsky S, Welker P, Fruhauf JH, Maslova L, Ivanova L, Jensen B, Markel AL, Bachmann S. Renal and endocrine changes in rats with inherited stress-induced arterial hypertension (ISIAH). Histochem Cell Biol. 2006;125:651-659.
49. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin- Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2009;296:F118-F126.